Charles and Colvard Ltd (CTHR) Actualités

Form 8-K - Current report

Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq

Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq PR Newswire RESEARCH TRIANGLE PARK...

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO

ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer...

Form 8-K - Current report

Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq

Charles & Colvard, Ltd. Receives Non-Compliance Letter from Nasdaq PR Newswire RESEARCH TRIANGLE PARK...

Charles & Colvard, Ltd. Comments on a Letter from Riverstyx Capital Management to Charles & Colvard Shareholders

Charles & Colvard, Ltd. Comments on a Letter from Riverstyx Capital Management to Charles & Colvard...

Form 8-K - Current report

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership